NUCALA
NUCALA
Approved
DIN Number
02492997
Drug Class
Human
Market Date
Dec 10, 2019
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02492997
AIG Number0157630001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
R03DX09 MEPOLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
MEPOLIZUMABActive
Strength: 100 MG / ML
Monograph: MEPOLIZUMAB